HOME >> MEDICINE >> NEWS
Patients at high risk of stroke may need to continue warfarin after heart rhythm is controlled

CHICAGO Treatment with warfarin, a medication that prevents blood clotting, may reduce the risk of stroke by more than two-thirds in patients with atrial fibrillation (AF), a condition which places them at high risk of stroke, according to a study in the May 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

An estimated 2,260,000 individuals in the U.S. have atrial fibrillation, an irregular heartbeat in which the upper chambers of the heart (the atria) beat inconsistently and rapidly, according to background information in the article. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM ) study, a large multi-center comparison study of the two strategies for treatment of atrial fibrillation, rate control or sinus rhythm control therapy, found no difference in the risk of death for patients treated with either of the two therapies. Treatment with the anticoagulant, warfarin, was included in both therapies, although patients in the sinus rhythm control group could stop warfarin after at least four weeks of maintained sinus rhythm while receiving an anti-arrhythmic drug.

David G. Sherman, M.D., of the University of Texas Health Science Center, San Antonio, and colleagues assessed the occurrence and characteristics of strokes in patients in both treatment groups in the follow-up to the AFFIRM study, ranging from two to six years. The researchers analyzed the relationship of a number of variables for risk of ischemic stroke, a stroke caused by decreased blood flow to an area of the brain, most commonly due to narrowing of blood vessels or an embolism (small blood clot) leading to blockage of the blood supply. Variables in the analysis included age, sex, and history of stroke, diabetes, coronary artery disease, high blood pressure and smoking. Eighty-four percent of the rate control patients and 52 percent of the sinus rhythm control patients received warfarin throughout the study.

The typ
'"/>

Contact: Will Sansom
210-567-2570
JAMA and Archives Journals
23-May-2005


Page: 1 2

Related medicine news :

1. Patients with soft tissue sarcomas should be treated at high volume centers
2. Patients with bleeding strokes less likely to get prevention treatment
3. Patients should be alert for obesity surgery complication
4. Patients with type 1 diabetes dont wake in response to hypoglycemia
5. Cancer Patients Nationwide Can More Easily Navigate Health Care System
6. Patients with PTSD experience less pain sensitivity -- may be related to altered processing
7. Patients requests for antidepressants can influence physician evaluation of depression
8. Patients unaware of risks and purpose of research even after informed consent
9. Patients can report statins adverse effects on new web site
10. National study: Patients poorly prepared for end-of-life decisions
11. Patients receiving treatment with radioisotopes may trigger security alarms

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... 19, 2019 , ... Marking a key milestone in the ... on Wednesday will lift into place the final steel beam at AHN ... year. , The nearly 79,000-square-foot facility – located at 6321 Route 30, Greensburg, ...
(Date:2/19/2019)... HILLS, Calif. (PRWEB) , ... February 19, 2019 ... ... Wachler Vision Institute, Brian Boxer Wachler, MD, has launched the first ever supplement ... that can lead to severe to severe vision loss. The supplement, KC Defense, ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... with town halls across the country , A partnership between Liberty University and ... crisis, continues with its next town hall event on Tuesday, February 19, at ...
(Date:2/19/2019)... JACKSONVILLE, Fla. (PRWEB) , ... February 19, 2019 ... ... professors say yes! , “Nova Filtration is based in The Villages FL proudly ... success in our new franchised Territory in the greater Jacksonville area selling and ...
(Date:2/19/2019)... ... February 19, 2019 , ... Dr. Lombardi is ... Oncology Institute of Hope and Innovation. , Dr. Lombardi completed his undergraduate in ... received his medical degree from the University of Rochester School of Medicine. He ...
Breaking Medicine News(10 mins):
(Date:2/16/2019)... ... February 15, 2019 , ... ... Allison Marlow of Perio-Implant Care are urging patients to take their oral health ... cancers, diabetes, Alzheimer's and dementia, and risk of pre-term birth, there is plenty ...
(Date:2/16/2019)... ... 15, 2019 , ... Dr. Lucas Bryant, board-certified Face expert ... Haute Beauty Network, well known for their exclusivity, and luxurious lifestyle, is privileged ... newest addition to the Haute Living partnership. , Haute Beauty offers a prominent ...
(Date:2/14/2019)... Colo. (PRWEB) , ... February 14, 2019 , ... ... Month , Lewis and Clark College Emeritus Professor of Education Gregory A. Smith ... They discuss the emergence of Brand Ambassador programs, a new phenomenon in the ...
Breaking Medicine Technology:
Cached News: